Patients With Diabetes and CRAO at Increased Risk for Ocular Neovascularization
Researchers recommend close, monthly monitoring up to 9 months after CRAO.
Researchers recommend close, monthly monitoring up to 9 months after CRAO.
At an abstract presented at MDS 2021, researchers described and analyzed eye movements in patients with an inborn errors of metabolism and their presence in early disease.
Visual treatments may provide modifiable risk factor for dementia.
The findings were particularly strong in patients who also experienced neurological symptoms.
Study researchers evaluated how gait patterns change across the spectrum of baseline visual field damage in glaucoma.
Dry eye disease affects nearly 7% of adults in the United States. Despite this, patients may not know many causes, symptoms, risk factors, and preventative measures for the disease. What should you be telling your patients about dry eye disease?
A uniform approach could help control pain in this densely innervated region of the body.
Investigators report that continuous treatment is important to ensure that the benefits are not lost due to recurrent NV activity.”
Researchers assessed the sensitivity of ultrasound halo features and their association with disease activity and glucocorticoid treatment in patients with newly diagnosed giant cell arteritis.
Study researchers sought to evaluate the role of tissue biopsy in diagnosis of a patient with progressive bilateral optic neuropathy.